UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

The Role of Hematopoietic Stem Cell Transplantation in CML

Chronic Myeloid Leukemia, 2021, p.159-178

Hehlmann, Rüdiger

2021

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib (Velcade)-thalidomide-dexamethasone is superior to thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation

BONE MARROW TRANSPLANTATION, 2011, Vol.46, p.S3

2011

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic myeloablative stem cell transplant as salvage therapy of reduced-intensity conditioned stem cell transplant: toxicity and outcome

BONE MARROW TRANSPLANTATION, 2006, Vol.37, p.S195

2006

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic myelo-ablative stem cell transplant (SCT) as salvage therapy of reduced-intensity conditioned (RIC) SCT: Toxicity and outcome

BLOOD, 2005, Vol.106 (11), p.1021A

2005

Link zum Volltext

Verfügbarkeit prüfen

NEOPTERIN EXCRETION DURING ALLOGENEIC, SYNGENEIC AND AUTOLOGOUS BONE MARROW TRANSPLANTATION

Cancer - Immunology - Metabolic Diseases, 2019, Vol.2, p.195-234

Originally published 1983, 2019

Link zum Volltext

Verfügbarkeit prüfen

URINARY NEOPTERIN EXCRETION IN THE FOLLOW UP OF BONE MARROW TRANSPLANT RECIPIENTS

February 23-March 2, 1985, St. Christoph, Arlberg, Austria, 2019, Vol.4, p.379-386

Originally published 1985, 2019

Link zum Volltext

Verfügbarkeit prüfen

Conventional HLA-identical sibling bone marrow transplantation is able to cure chronic lymphocytic leukaemia. A study from the EBMT and IBMT Registries

BONE MARROW TRANSPLANTATION, 2004, Vol.33, p.S148

2004

Link zum Volltext

Verfügbarkeit prüfen

Low initial cell dose and escalating dose regimen is the best method of administering unmanipulated donor lymphocytes for relapsed chronic myelogenous leukemia

BLOOD, 2002, Vol.100 (11), p.635A

2002

Link zum Volltext

Verfügbarkeit prüfen

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: The first dose decides outcome

BLOOD, 2001, Vol.98 (11), p.727A

2001

Link zum Volltext

Verfügbarkeit prüfen

Reduced intensity conditioned allografts for chronic myeloid leukaemia: A study from the chronic leukaemia working party of the EBMT

BLOOD, 2002, Vol.100 (11), p.781A

2002

Link zum Volltext

Verfügbarkeit prüfen

Reduced intensity conditioned allografts for myeloma: A study from the Chronic Leukaemia Working Party of the EBMT

Blood, 2002, Vol.100 (11), p.542

2002

Link zum Volltext

Verfügbarkeit prüfen

Reduced intensity conditioned allografts for chronic myeloid leukaemia: A study from the chronic leukaemia working party of the EBMT

Blood, 2002, Vol.100 (11), p.3089

2002

Link zum Volltext

Verfügbarkeit prüfen

Outcome of blood and marrow transplants in Europe

BONE MARROW TRANSPLANTATION, 1999, Vol.23, p.S184

1999

Link zum Volltext

Verfügbarkeit prüfen

Concomitant hairy cell and acute myeloid leukemia

European Journal of Haematology, 2006, Vol.76 (1), p.86-88

2006

Link zum Volltext

Verfügbarkeit prüfen

Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease

Annals of the rheumatic diseases, 2008, Vol.67 (7), p.1057-1059

2008

Link zum Volltext

Verfügbarkeit prüfen

Bone Marrow Transplantation with Ciclosporin

Ciclosporin, 1986, Vol.38, p.404-431

1986

Link zum Volltext

Verfügbarkeit prüfen

Bone Marrow Transplantation with Ciclosporin

Ciclosporin, 1986, Vol.38, p.404-431

1986

Link zum Volltext

Verfügbarkeit prüfen

Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment

Bone marrow transplantation, 2007, Vol.40 (6), p.597-598

2007

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic bone marrow transplantation in multiple myeloma

BONE MARROW TRANSPLANTATION, 1998, Vol.21, p.S204

1998

Link zum Volltext

Verfügbarkeit prüfen

Autologous (ABMT) versus unrelated (MUD) marrow transplantation for acute leukemia. A retrospective survey from the European cooperative group for blood and marrow transplantation (EBMT)

BLOOD, 1995, Vol.86 (10), p.2454

1995

Link zum Volltext

Verfügbarkeit prüfen

Haematopoietic precursor cell transplants - Main risk factors

BLOOD, 1995, Vol.86 (10), p.2460

1995

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow transplantation for AML; An update of the EBMT registration study

BRITISH JOURNAL OF HAEMATOLOGY, 1996, Vol.93, p.520

1996

Link zum Volltext

Verfügbarkeit prüfen

Second transplants for leukaemic relapse after bone marrow transplantation : high early mortality but favourable effect of chronic GVHD on continued remission : a report by the EMBT leukaemia working party

British journal of haematology, 1991, Vol.79 (4), p.567-574

1991

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow transplantation from HLA-identical siblings as first line treatment in patients with myelodysplastic syndromes or secondary acute myelogenous leukemia: A European survey

BLOOD, 1995, Vol.86 (10), p.369

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(38)

Publikationsform

Sprache

Englisch
(41)
Deutsch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The Role of Hematopoietic Stem Cell Transplantation in CML

Bortezomib (Velcade)-thalidomide-dexamethasone is superior to thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation

Bortezomib(Velcade (R))-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation

Allogeneic myeloablative stem cell transplant as salvage therapy of reduced-intensity conditioned stem cell transplant: toxicity and outcome

Allogeneic myelo-ablative stem cell transplant (SCT) as salvage therapy of reduced-intensity conditioned (RIC) SCT: Toxicity and outcome

NEOPTERIN EXCRETION DURING ALLOGENEIC, SYNGENEIC AND AUTOLOGOUS BONE MARROW TRANSPLANTATION

URINARY NEOPTERIN EXCRETION IN THE FOLLOW UP OF BONE MARROW TRANSPLANT RECIPIENTS

Conventional HLA-identical sibling bone marrow transplantation is able to cure chronic lymphocytic leukaemia. A study from the EBMT and IBMT Registries

Low initial cell dose and escalating dose regimen is the best method of administering unmanipulated donor lymphocytes for relapsed chronic myelogenous leukemia

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: The first dose decides outcome

Reduced intensity conditioned allografts for chronic myeloid leukaemia: A study from the chronic leukaemia working party of the EBMT

Reduced intensity conditioned allografts for myeloma: A study from the Chronic Leukaemia Working Party of the EBMT

Reduced intensity conditioned allografts for chronic myeloid leukaemia: A study from the chronic leukaemia working party of the EBMT

Outcome of blood and marrow transplants in Europe

Concomitant hairy cell and acute myeloid leukemia

Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease

Bone Marrow Transplantation with Ciclosporin

Bone Marrow Transplantation with Ciclosporin

Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment

Allogeneic bone marrow transplantation in multiple myeloma

Autologous (ABMT) versus unrelated (MUD) marrow transplantation for acute leukemia. A retrospective survey from the European cooperative group for blood and marrow transplantation (EBMT)

Haematopoietic precursor cell transplants - Main risk factors

Bone marrow transplantation for AML; An update of the EBMT registration study

Second transplants for leukaemic relapse after bone marrow transplantation : high early mortality but favourable effect of chronic GVHD on continued remission : a report by the EMBT leukaemia working party

Bone marrow transplantation from HLA-identical siblings as first line treatment in patients with myelodysplastic syndromes or secondary acute myelogenous leukemia: A European survey

Aktive Filter

Suchergebnisse filtern